Richard S Schottenfeld, MD

Senior Research Scientist

Departments & Organizations

Psychiatry: Addictions, Division of | Connecticut Mental Health Center | Psychotherapy Development Center | Substance Abuse Research | Yale Global Mental Health Program

Center for Interdisciplinary Research on AIDS

Faculty Research

Yale Medicine

Global Health Studies: Social & Behavioral Health

Office of Cooperative Research

Yale Institute for Global Health

Biography

Dr Schottenfeld is an experienced clinician, teacher and
clinical researcher who has focused on improving the efficacy, accessibility
and availability of addictions treatment in the United
States and internationally (in Malaysia,
Iran and China.) In clinical trials and clinical epidemiologic
studies, he has developed new programs that integrate addictions treatment and
general medical services and has evaluated the pharmacological and behavioral
components of different treatments for opioid dependence and other addictive
disorders. In his clinical, administrative and teaching roles, he oversaw
development of a multi-component drug abuse treatment program providing
innovative ambulatory and residential treatment for addictive disorders and was
the founding Director of the Addiction Psychiatry Residency Training Program
and the drug abuse clinical research post-doctoral training program at Yale.

Education & Training

MD Yale University (1976)

Honors & Recognition

  • Nyswander-Dole AwardAmerican Association for the Treatment of Opioid Dependence (2004)

Activities

  • Malaysia, Iran, HIV, Drug abuse, Opioid, Cocaine Malaysia (2010)

    Improving Efficacy of Drug Abuse Treatment

  • Malaysia, Heroin, HIV Malaysia (2010)

    Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia

  • Opioid dependence Wuhan, China (2007 - 2014)

    We have developed a program of clinical research aimed at evaluating, improving and disseminating cost-effective treatments for heroin or other opioid dependence in Malaysia, Iran, and China.

  • Opioid dependence Tehran, Iran (2003 - 2012)

    We have developed a program of clinical research aimed at evaluating, improving and disseminating cost-effective treatments for heroin or other opioid dependence in Malaysia, Iran, and China.

  • Opioid Dependence Muar, Malaysia (2001 - 2014)

    We have developed a program of clinical research aimed at evaluating, improving and disseminating cost-effective treatments for heroin or other opioid dependence in Malaysia, Iran, and China.

Edit this profile